Published in Respiratory Therapeutics Week, August 2nd, 2004
VIASYS earlier filed a complaint against Innomed Technologies Inc. in the U.S. District Court for the Central District of California seeking a declaration that the LYRA product does not infringe a patent that Innomed alleges it owns. While the court dismissed the complaint on procedural grounds, it made no findings on the merits of the case and did not find that the LYRA product infringes Innomed's patent.
Subsequently, Innomed brought a patent infringement action against VIASYS in the U.S. District Court for the Middle District of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.